ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Puma Biotechnology, Inc. ?
1
Company has a low Debt to Equity ratio (avg) at times
2
Positive results in Sep 25
- OPERATING CASH FLOW(Y) Highest at USD 42.99 MM
- NET PROFIT(9M) At USD 17.67 MM has Grown at 61.06%
- DEBT-EQUITY RATIO (HY) Lowest at -48.09 %
3
With ROE of 32.08%, it has a attractive valuation with a 2.68 Price to Book Value
- Over the past year, while the stock has generated a return of 83.23%, its profits have risen by 59.1% ; the PEG ratio of the company is 0.1
4
High Institutional Holdings at 94.41%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 6.98% over the previous quarter.
5
Market Beating performance in long term as well as near term
- Along with generating 83.23% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Puma Biotechnology, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Puma Biotechnology, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Puma Biotechnology, Inc.
78.06%
1.03
73.31%
S&P 500
16.12%
0.77
19.29%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-2.08%
EBIT Growth (5y)
26.20%
EBIT to Interest (avg)
1.37
Debt to EBITDA (avg)
0.17
Net Debt to Equity (avg)
-0.32
Sales to Capital Employed (avg)
1.52
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
94.41%
ROCE (avg)
111.58%
ROE (avg)
32.87%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
2.68
EV to EBIT
7.41
EV to EBITDA
5.56
EV to Capital Employed
4.52
EV to Sales
1.17
PEG Ratio
0.14
Dividend Yield
NA
ROCE (Latest)
61.04%
ROE (Latest)
32.08%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend10What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 42.99 MM
NET PROFIT(9M)
At USD 17.67 MM has Grown at 61.06%
DEBT-EQUITY RATIO
(HY)
Lowest at -48.09 %
INTEREST COVERAGE RATIO(Q)
Highest at 825.72
RAW MATERIAL COST(Y)
Fallen by -21.92% (YoY
-8What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 8.06 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 4.81 times
NET SALES(Q)
At USD 54.48 MM has Fallen at -8.47%
NET PROFIT(Q)
At USD 8.84 MM has Fallen at -26.99%
Here's what is working for Puma Biotechnology, Inc.
Operating Cash Flow
Highest at USD 42.99 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Interest Coverage Ratio
Highest at 825.72
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Debt-Equity Ratio
Lowest at -48.09 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -21.92% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Puma Biotechnology, Inc.
Net Sales
At USD 54.48 MM has Fallen at -8.47%
over average net sales of the previous four periods of USD 59.52 MMMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Net Profit
At USD 8.84 MM has Fallen at -26.99%
over average net sales of the previous four periods of USD 12.11 MMMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Inventory Turnover Ratio
Lowest at 8.06 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 4.81 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
